ABS Biotechnologies offers a comprehensive hiPSC reprogramming service, generating high-quality induced pluripotent stem cells (iPSCs) from both fibroblasts and peripheral blood mononuclear cells (PBMCs) for clients worldwide. Whether you are establishing disease models, building biobanks, or advancing cell therapy research, we deliver reliable, research-grade iPSC lines tailored to your project.
Our world-leading team of experienced and passionate stem cell biologists has spent more than two decades at the forefront of stem cell science. We previously established and operated the world's largest stem cell pipeline in Cambridge, UK, giving us unparalleled expertise in high-throughput, high-quality hiPSC generation. We understand the technical challenges and research requirements because we've been solving them for years.
Every hiPSC line undergoes comprehensive quality control to ensure the highest standards of quality and reproducibility. Our standard QC includes:
We generate hiPSC lines from peripheral blood mononuclear cells (PBMCs) isolated from whole blood. Following PBMC isolation, cells are expanded through an erythroblast intermediate before reprogramming into high-quality hiPSC lines.
We generate hiPSC lines from dermal fibroblasts obtained from skin biopsy samples. Fibroblasts are expanded under controlled conditions before reprogramming into high-quality hiPSC lines.
We offer genomic engineering of hiPSC lines to generate precise gene knockouts, knock-ins, point mutations, and isogenic control lines tailored to your research needs.
New treatments have to be safe.
